Axxcess Wealth Management LLC Has $2.13 Million Stock Position in The Clorox Company (NYSE:CLX)

Axxcess Wealth Management LLC lowered its holdings in The Clorox Company (NYSE:CLX) by 2.8% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 13,088 shares of the company’s stock after selling 378 shares during the quarter. Axxcess Wealth Management LLC’s holdings in Clorox were worth $2,132,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Innealta Capital LLC bought a new stake in shares of Clorox in the 2nd quarter worth approximately $30,000. Trifecta Capital Advisors LLC increased its stake in shares of Clorox by 139.8% in the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock valued at $30,000 after buying an additional 130 shares during the period. First Foundation Advisors acquired a new stake in shares of Clorox during the first quarter worth $31,000. Family Firm Inc. acquired a new stake in shares of Clorox during the second quarter worth $31,000. Finally, Quarry LP lifted its holdings in Clorox by 99.1% during the second quarter. Quarry LP now owns 229 shares of the company’s stock worth $31,000 after acquiring an additional 114 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Price Performance

Shares of NYSE CLX opened at $165.05 on Tuesday. The business’s 50 day moving average price is $162.14 and its two-hundred day moving average price is $146.83. The company has a market cap of $20.43 billion, a PE ratio of 57.51, a price-to-earnings-growth ratio of 3.05 and a beta of 0.41. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The Clorox Company has a twelve month low of $127.60 and a twelve month high of $169.09.

Clorox (NYSE:CLX) last posted its earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, beating the consensus estimate of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The company had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter in the prior year, the business earned $0.49 earnings per share. The firm’s revenue for the quarter was up 27.0% on a year-over-year basis. On average, analysts predict that The Clorox Company will post 6.85 EPS for the current year.

Clorox Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd were given a $1.22 dividend. This represents a $4.88 annualized dividend and a dividend yield of 2.96%. The ex-dividend date was Wednesday, October 23rd. Clorox’s payout ratio is 170.04%.

Insider Activity

In related news, EVP Angela C. Hilt sold 1,733 shares of the stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the sale, the executive vice president now owns 13,471 shares of the company’s stock, valued at $2,229,719.92. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 0.57% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on the company. Evercore ISI reduced their target price on Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a report on Monday, October 14th. BNP Paribas upgraded Clorox to a “strong sell” rating in a report on Friday, September 6th. Jefferies Financial Group upgraded Clorox from a “hold” rating to a “buy” rating and boosted their price target for the company from $174.00 to $187.00 in a report on Tuesday, October 1st. JPMorgan Chase & Co. boosted their price target on Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a report on Friday, October 11th. Finally, DA Davidson boosted their price target on Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a report on Monday, November 4th. Five equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $155.00.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.